Cargando…

The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention

The field of the long non-coding RNA (lncRNA) is advancing rapidly. Currently, it is one of the most popular fields in the biological and medical sciences. It is becoming increasingly obvious that the majority of the human transcriptome has little or no-protein coding capacity. Historically, H19 was...

Descripción completa

Detalles Bibliográficos
Autores principales: Matouk, Imad, Raveh, Eli, Ohana, Patricia, Lail, Rasha Abu, Gershtain, Eitan, Gilon, Michal, De Groot, Nathan, Czerniak, Abraham, Hochberg, Abraham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3588099/
https://www.ncbi.nlm.nih.gov/pubmed/23429271
http://dx.doi.org/10.3390/ijms14024298
_version_ 1782261499122679808
author Matouk, Imad
Raveh, Eli
Ohana, Patricia
Lail, Rasha Abu
Gershtain, Eitan
Gilon, Michal
De Groot, Nathan
Czerniak, Abraham
Hochberg, Abraham
author_facet Matouk, Imad
Raveh, Eli
Ohana, Patricia
Lail, Rasha Abu
Gershtain, Eitan
Gilon, Michal
De Groot, Nathan
Czerniak, Abraham
Hochberg, Abraham
author_sort Matouk, Imad
collection PubMed
description The field of the long non-coding RNA (lncRNA) is advancing rapidly. Currently, it is one of the most popular fields in the biological and medical sciences. It is becoming increasingly obvious that the majority of the human transcriptome has little or no-protein coding capacity. Historically, H19 was the first imprinted non-coding RNA (ncRNA) transcript identified, and the H19/IGF2 locus has served as a paradigm for the study of genomic imprinting since its discovery. In recent years, we have extensively investigated the expression of the H19 gene in a number of human cancers and explored the role of H19 RNA in tumor development. Here, we discuss recently published data from our group and others that provide further support for a central role of H19 RNA in the process of tumorigenesis. Furthermore, we focus on major transcriptional modulators of the H19 gene and discuss them in the context of the tumor-promoting activity of the H19 RNA. Based on the pivotal role of the H19 gene in human cancers, we have developed a DNA-based therapeutic approach for the treatment of cancers that have upregulated levels of H19 expression. This approach uses a diphtheria toxin A (DTA) protein expressed under the regulation of the H19 promoter to treat tumors with significant expression of H19 RNA. In this review, we discuss the treatment of four cancer indications in human subjects using this approach, which is currently under development. This represents perhaps one of the very few examples of an existing DNA-based therapy centered on an lncRNA system. Apart from cancer, H19 expression has been reported also in other conditions, syndromes and diseases, where deregulated imprinting at the H19 locus was obvious in some cases and will be summarized below. Moreover, the H19 locus proved to be much more complicated than initially thought. It houses a genomic sequence that can transcribe, yielding various transcriptional outputs, both in sense and antisense directions. The major transcriptional outputs of the H19 locus are presented here.
format Online
Article
Text
id pubmed-3588099
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-35880992013-03-13 The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention Matouk, Imad Raveh, Eli Ohana, Patricia Lail, Rasha Abu Gershtain, Eitan Gilon, Michal De Groot, Nathan Czerniak, Abraham Hochberg, Abraham Int J Mol Sci Review The field of the long non-coding RNA (lncRNA) is advancing rapidly. Currently, it is one of the most popular fields in the biological and medical sciences. It is becoming increasingly obvious that the majority of the human transcriptome has little or no-protein coding capacity. Historically, H19 was the first imprinted non-coding RNA (ncRNA) transcript identified, and the H19/IGF2 locus has served as a paradigm for the study of genomic imprinting since its discovery. In recent years, we have extensively investigated the expression of the H19 gene in a number of human cancers and explored the role of H19 RNA in tumor development. Here, we discuss recently published data from our group and others that provide further support for a central role of H19 RNA in the process of tumorigenesis. Furthermore, we focus on major transcriptional modulators of the H19 gene and discuss them in the context of the tumor-promoting activity of the H19 RNA. Based on the pivotal role of the H19 gene in human cancers, we have developed a DNA-based therapeutic approach for the treatment of cancers that have upregulated levels of H19 expression. This approach uses a diphtheria toxin A (DTA) protein expressed under the regulation of the H19 promoter to treat tumors with significant expression of H19 RNA. In this review, we discuss the treatment of four cancer indications in human subjects using this approach, which is currently under development. This represents perhaps one of the very few examples of an existing DNA-based therapy centered on an lncRNA system. Apart from cancer, H19 expression has been reported also in other conditions, syndromes and diseases, where deregulated imprinting at the H19 locus was obvious in some cases and will be summarized below. Moreover, the H19 locus proved to be much more complicated than initially thought. It houses a genomic sequence that can transcribe, yielding various transcriptional outputs, both in sense and antisense directions. The major transcriptional outputs of the H19 locus are presented here. MDPI 2013-02-21 /pmc/articles/PMC3588099/ /pubmed/23429271 http://dx.doi.org/10.3390/ijms14024298 Text en © 2013 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Matouk, Imad
Raveh, Eli
Ohana, Patricia
Lail, Rasha Abu
Gershtain, Eitan
Gilon, Michal
De Groot, Nathan
Czerniak, Abraham
Hochberg, Abraham
The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention
title The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention
title_full The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention
title_fullStr The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention
title_full_unstemmed The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention
title_short The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention
title_sort increasing complexity of the oncofetal h19 gene locus: functional dissection and therapeutic intervention
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3588099/
https://www.ncbi.nlm.nih.gov/pubmed/23429271
http://dx.doi.org/10.3390/ijms14024298
work_keys_str_mv AT matoukimad theincreasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT raveheli theincreasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT ohanapatricia theincreasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT lailrashaabu theincreasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT gershtaineitan theincreasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT gilonmichal theincreasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT degrootnathan theincreasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT czerniakabraham theincreasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT hochbergabraham theincreasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT matoukimad increasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT raveheli increasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT ohanapatricia increasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT lailrashaabu increasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT gershtaineitan increasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT gilonmichal increasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT degrootnathan increasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT czerniakabraham increasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention
AT hochbergabraham increasingcomplexityoftheoncofetalh19genelocusfunctionaldissectionandtherapeuticintervention